台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    84.9
  • 漲跌
    ▲0.4
  • 漲幅
    +0.47%
  • 成交量
    471
  • 產業
    上櫃 生技醫療類股
  • 318人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
中裕 (4147)籌碼相關-國泰 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國泰 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/163587.2000.0086.50351,1333.09%
2025/01/143989.60187.7087.30381,1473.31%
2025/01/1300.00489.6089.90-41,132-0.35%
2025/01/10190.2000.0090.5011,0640.09%
2025/01/09391.938488.7887.50-811,014-7.99%
2025/01/084101.13498.7097.2008720.00%
2025/01/0700.003592.0992.70-35649-5.39%
2025/01/061190.00189.8089.80106111.63%
2025/01/03288.6000.0088.3026000.33%
2025/01/022688.0700.0087.00265914.40%
2024/12/3000.00386.0085.50-3593-0.51%
2024/12/2700.004786.3485.80-47593-7.91%
2024/12/191083.00882.3582.5026150.33%
2024/12/18582.0000.0082.9056260.80%
2024/12/17382.00281.9082.0016250.16%
2024/12/1600.00283.0081.80-2631-0.32%
2024/12/1300.001483.6983.00-14627-2.23%
2024/12/1100.002086.7486.00-20621-3.22%
2024/12/10190.0000.0087.5016150.16%
2024/12/091889.62688.1290.10126002.00%
2024/12/067287.712786.7587.60455737.85%
2024/12/054085.2900.0085.00405277.58%
2024/12/035385.4500.0084.305352910.01%
2024/12/027585.0500.0084.207552414.29%
2024/11/293284.7300.0084.30325246.10%
2024/11/2200.00180.6079.90-1512-0.20%
2024/11/20178.3000.0079.0015150.19%
2024/11/1317081.9000.0081.7017053731.60% 大買/鉅額交易
2024/10/24880.4000.0080.8085721.40%
2024/10/235081.6400.0081.80505708.76%
2024/10/0700.003978.0477.80-39629-6.20%
2024/10/04678.95678.7878.2006290.00%
2024/08/305186.3600.0086.40517506.79%
2024/08/2800.001784.5183.70-17733-2.32%
2024/08/1900.001180.3779.40-11752-1.46%
2024/08/07273.1000.0075.6027790.26%
2024/08/06368.773069.0070.30-27771-3.50%
2024/08/05174.00274.8074.00-1734-0.14%
2024/07/30182.6000.0083.9017370.14%
2024/07/291283.99083.5082.60127411.62%
2024/07/19489.751890.2886.50-14727-1.92%
2024/07/184088.4500.0088.40407095.64%
2024/07/1700.00488.5088.10-4713-0.56%
2024/07/09284.6000.0084.1028100.25%
2024/07/02788.9100.0088.6079920.71%
2024/07/0100.001490.1690.20-141,096-1.28%
2024/06/24188.0000.0086.7011,1280.09%
2024/06/2000.00590.2889.90-51,128-0.44%
2024/06/1700.00192.0091.50-11,153-0.09%
2024/06/12191.10291.2091.00-11,174-0.09%
2024/06/113392.433791.8591.00-41,182-0.34%
2024/06/07188.40189.8090.1001,1670.00%
2024/06/0610089.451490.3789.40861,1967.19%
2024/06/05590.0000.0090.3051,2370.40%
2024/06/041190.1000.0089.50111,3170.83%
2024/05/3100.00188.5090.10-11,420-0.07%
2024/05/29990.061090.4589.10-11,511-0.07%
2024/05/2700.001087.7887.50-101,701-0.59%
2024/05/24286.7000.0087.2021,8690.11%
2024/05/2310087.9300.0087.101002,0144.96%
2024/05/2100.004688.8288.00-462,123-2.17%
2024/05/17588.504487.8887.70-392,170-1.80%
2024/05/1600.00586.6086.90-52,189-0.23%
2024/05/15186.80487.8086.40-32,211-0.14%
2024/05/1400.002587.7887.40-252,250-1.11%
2024/05/1000.001286.5486.50-122,285-0.53%
2024/05/09285.9000.0085.7022,3370.09%
2024/05/08487.3500.0086.7042,3350.17%
2024/05/071987.21286.7086.70172,3360.73%
2024/05/061687.792088.1388.00-42,331-0.17%
2024/05/0300.002585.5285.80-252,318-1.08%
2024/04/30185.2000.0085.5012,3290.04%
2024/04/26583.1000.0083.0052,3240.22%
2024/04/25183.0000.0082.5012,3250.04%
2024/04/24884.0300.0084.8082,3210.34%
2024/04/23382.87283.3082.8012,3280.04%
2024/04/22182.8000.0081.8012,3290.04%
2024/04/19884.1900.0083.1082,3340.34%
2024/04/18187.0000.0086.8012,3570.04%
2024/04/17988.2800.0087.8092,3560.38%
2024/04/16488.4000.0087.9042,3510.17%
2024/04/15591.5000.0090.1052,3420.21%
2024/04/12495.183094.1394.00-262,339-1.11%
2024/04/1100.001.195.2495.80-1.12,349-0.05%
2024/04/10494.5312696.1693.20-1222,339-5.21% 大賣/鉅額交易
2024/04/092296.056696.2996.20-442,301-1.91%
2024/04/0881.192.9600.0093.0081.12,2363.63%
2024/04/03890.3326.190.0090.60-18.12,195-0.83%
2024/04/02288.6000.0088.5022,0880.10%
2024/04/014090.92889.9090.10322,0741.54%
2024/03/26388.5000.0088.1032,0330.15%
2024/03/25188.3000.0087.8012,0270.05%
2024/03/221489.1000.0088.80142,0200.69%
2024/03/214088.7000.0088.60402,0141.99%
2024/03/19191.0000.0091.1011,9880.05%
2024/03/18389.6300.0091.3031,9810.15%
2024/03/14291.5000.0091.7021,9600.10%
2024/03/13891.192690.9690.90-181,947-0.92%
2024/03/12792.80291.9091.9051,9440.26%
2024/03/113294.43394.4094.10291,9071.52%
2024/03/08898.5910097.7696.80-921,865-4.93%
2024/03/0611102.9120103.50103.50-91,735-0.52%
2024/03/0556106.1422105.70102.50341,7042.00%
2024/03/0474109.0131108.52109.00431,6412.62%
2024/03/0155108.03208109.07109.00-1531,602-9.55% 大賣/鉅額交易
2024/02/2973109.56221108.51110.50-1481,559-9.49% 大賣/鉅額交易
2024/02/27147113.8898113.54114.00491,4133.47% 大買/
2024/02/26372108.7328108.11108.003441,24727.57% 大買/鉅額交易
2024/02/2312103.128104.50102.5041,1070.36%
2024/02/053090.2600.0088.70309783.07%
2024/02/0200.00390.1389.80-3993-0.30%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章